Search

Showing "11154" results for ""

Diabetes drug and exercise help reduce heart disease risk and improve body shape in HAART patients

Women with HIV have reduced bone density, may benefit from regular checks

Tenofovir/FTC once daily tablet ready by 2005

Less HAART use, more unsafe sex, could mean 50% leap in new HIV cases in Aussie gay men

Regions with fastest growing HIV epidemics have worst rates of MDR-TB says WHO

Tipranavir emergency use programme expands

Cheap tests good predictors of disease progression after starting HAART

Unexpected CD4 declines seen on full dose ddI with tenofovir

Consistent condom use associated with regression of CIN and clearance of HPV in Dutch studies

Kaletra may cause fewer lipid abnormalities than previously thought in HIV-positive

Kaletra leads to significant increases in some blood lipids in HIV-negative men

Fixed-dose ARV combinations: choices and challenges

CSF abnormalities less likely to normalise in HIV-positive patients treated for neurosyphilis

Can HAART prevent SARS?

Need for new TB test highlighted on World TB Day

Kidney stones and other calculus build-up seen in 4% of those on Kaletra-based HAART

HAART takes more than a year to suppress Kaposi’s sarcoma virus

Atazanavir interactions with tenofovir and Viagra included on new US labelling

Receive the latest HIV research and conference news

Showing "11154" results for ""

Diabetes drug and exercise help reduce heart disease risk and improve body shape in HAART patients

Women with HIV have reduced bone density, may benefit from regular checks

Tenofovir/FTC once daily tablet ready by 2005

Less HAART use, more unsafe sex, could mean 50% leap in new HIV cases in Aussie gay men

Regions with fastest growing HIV epidemics have worst rates of MDR-TB says WHO

Tipranavir emergency use programme expands

Cheap tests good predictors of disease progression after starting HAART

Unexpected CD4 declines seen on full dose ddI with tenofovir

Consistent condom use associated with regression of CIN and clearance of HPV in Dutch studies

Kaletra may cause fewer lipid abnormalities than previously thought in HIV-positive

Kaletra leads to significant increases in some blood lipids in HIV-negative men

Fixed-dose ARV combinations: choices and challenges

CSF abnormalities less likely to normalise in HIV-positive patients treated for neurosyphilis

Can HAART prevent SARS?

Need for new TB test highlighted on World TB Day

Kidney stones and other calculus build-up seen in 4% of those on Kaletra-based HAART

HAART takes more than a year to suppress Kaposi’s sarcoma virus

Atazanavir interactions with tenofovir and Viagra included on new US labelling

Receive the latest HIV research and conference news